Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
L‐Huperzine‐A (Hup‐A), a natural cholinesterase inhibitor (ChEI) derived from the Chinese herb Huperzia serrata, was administered systemically (i.p.) or locally through the microdialysis probe into the rat cortex. Systemic Hup‐A significantly increased acetylcholine (ACh) levels above baseline at doses of 0.1, 0.3, and 0.5 mg/kg; the increases were 54%, 129%, and 220%, respectively. Norepinephrine (NE) and dopamine (DA) levels were also increased 121% and 129% above baseline at 0.3 mg/kg, and 143% and 153% at 0.5 mg/kg. Peak cholinesterase (ChE) inhibition was 23% at 60 min with the 0.3 mg/kg dose. Huperzine‐A, perfused through the microdialysis probe, produced a maximal increase of ACh levels of 3090% and 7790% at concentrations of 5 and 50 μM. The ACh increase seen at both concentrations lasted at least 6 hr. At the 5‐μM dose, NE and DA were increased by 214% and 386%; at the 50‐μM dose, NE and DA were increased by 216% and 1141%. There were no changes of 5‐HT levels. With local administration (via the probe), both doses produced facialforelimb seizures that lasted throughout the perfusion. Our results show that Hup‐A is a potent inhibitor of ChE which penetrates into the brain and produces a dose‐dependent increase of ACh, NE, and DA in rat cortex. This effect is seen with both systemic and local intracerebral administration, suggesting cortical as well as subcortical effects of the drug. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
The role of dopamine in locomotor activity and learning
Beninger, R. J. (1983) · Brain Research Reviews · doi:10.1016/0165-0173(83)90038-3 · Cited by 848 · cited 1×
“Recently, biochemical, electrophysiological, and behavioral studies have indicated interactions between the cholinergic system and noradrenergic system, as well as the dopaminergic system (Decker and McGaugh, 1991; Wise, 1978; Beninger, 1983).”
Background
Cited by
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477
Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1
WANG, R., YAN, H., & TANG, X.-C. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00255.x · Cited by 470
Cholinesterase Inhibitors and Beyond
Pepeu, G., & Giovannini, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509787602861 · Cited by 209
“Behavioral studies on huperzine A may help clarify this point since this drug, administered systemically or by reverse microdialysis in the cerebral cortex, brings about a dose-dependent increase in extracellular levels of ACh, noradrenaline and dopamine [37].”
BackgroundNeuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease
Zhang, H. Y., & Tang, X. C. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.004 · Cited by 174
Metadata
- Authors
- Zhu, X. ‐., & Giacobini, E.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1995-08-15
- Volume
- 41
- Issue
- 6
- Pages
- 828-835
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2168481396
- Cited by
- 39
- References
- 3
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines. https://app.cochat.ai/papers/10.1002/jnr.490410613
- The paper
- Zhu, X. ‐., & Giacobini, E. (1995). Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.490410613
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.